Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-5920 in Involutional Osteoporosis
NCT00212628Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minodronic acid in involutional osteoporosis, sponsored by Ono Pharmaceutical. Started Jun 2004; status: completed.
02
Drugs
minodronic acid
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on NCT00212628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212628.